Losartan Prevents Portal Hypertension-Induced, Redox-Mediated Endothelial Dysfunction in the Mesenteric Artery in Rats-Reference-Cited by-同舟云学术

Losartan Prevents Portal Hypertension-Induced, Redox-Mediated Endothelial Dysfunction in the Mesenteric Artery in Rats

Published:2010-04 Issue:4 Volume:138 Page:1574-1584
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Dal–Ros Stéphanie,Oswald–Mammosser Monique,Pestrikova Tatiana,Schott Christa,Boehm Nelly,Bronner Christian,Chataigneau Thierry,Gény Bernard,Schini–Kerth Valérie B.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Mild increases in portal pressure up-regulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state;Abraldes;Am J Physiol Gastrointest Liver Physiol,2006

2. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats;Nunes;Am J Respir Crit Care Med,2001

3. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat;Ling;Hepatology,2004

4. Analysis of pulmonary heme and oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome;Zhang;Gastroenterology,2003

5. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats;Sztrymf;Eur Respir J,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MPO Mediated Precise Inflammation Targeting of Antioxidant Melanin Nanomedicines as an Effective Therapeutic Strategy for Chronic Inflammation;2024-08-02

2. Effects of Resveratrol on Vascular Function in Retinal Ischemia-Reperfusion Injury;Antioxidants;2023-04-01

3. Role of the posterior mucosal defense barrier in portal hypertensive gastropathy;Biomedicine & Pharmacotherapy;2021-12

4. DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility;Life Sciences;2021-11

5. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats;Clinics and Research in Hepatology and Gastroenterology;2019-06